tag:www.gov.uk,2005:/drug-safety-updateDrug Safety Update about Emergency medicine2026-05-11T14:29:47+01:00HM Governmenttag:www.gov.uk,2005:/drug-safety-update/finasteride-and-dutasteride-updated-safety-warnings-for-psychiatric-side-effects-and-sexual-dysfunction2026-05-11T14:29:47+01:00Finasteride and Dutasteride – updated safety warnings for psychiatric side effects and sexual dysfunctionThe MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk. tag:www.gov.uk,2005:/drug-safety-update/nasal-decongestant-sprays-and-drops-containing-xylometazoline-hydrochloride-slash-oxymetazoline-hydrochloride-increased-risk-of-rebound-congestion-rhinitis-medicamentosa-and-tachyphylaxis-with-overuse2026-04-30T14:01:45+01:00Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphylaxis with overuse There have been reports of worsening nasal congestion (rebound congestion) when the effects of nasal decongestant sprays or drops containing xylometazoline hydrochloride and oxymetazoline hydrochloride, wear off.tag:www.gov.uk,2005:/drug-safety-update/falsified-mounjaro-kwikpen-15mg-pre-filled-pens2026-02-24T14:00:08+00:00Falsified Mounjaro KwikPen 15mg pre-filled pens A falsified version of Mounjaro (tirzepatide) KwikPen 15mg solution for injection has been found supplied through one online pharmacy in the UK. The falsified product is labelled with batch D873576 and applies to Mounjaro Kw…tag:www.gov.uk,2005:/drug-safety-update/semaglutide-wegovy-ozempic-and-rybelsus-risk-of-non-arteritic-anterior-ischemic-optic-neuropathy-naion2026-02-05T13:24:42+00:00Semaglutide (Wegovy, Ozempic and Rybelsus): risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)Non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden deterioration in vision, usually in one eye at a time, has been very rarely reported in association with semaglutide in the treatmen…tag:www.gov.uk,2005:/drug-safety-update/glp-1-receptor-agonists-and-dual-glp-1-slash-gip-receptor-agonists-strengthened-warnings-on-acute-pancreatitis-including-necrotising-and-fatal-cases2026-01-29T14:07:50+00:00GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis, including necrotising and fatal casesThe product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists has been further updated to highlight the potential risk o…tag:www.gov.uk,2005:/drug-safety-update/mesalazine-and-idiopathic-intracranial-hypertension2025-12-04T14:00:32+00:00Mesalazine and idiopathic intracranial hypertensionIdiopathic intracranial hypertension (IIH) has been very rarely reported in patients treated with mesalazine. Following a recent review, warnings for IIH are being added to the product information for all mesalazine products…tag:www.gov.uk,2005:/drug-safety-update/number-medsafetyweek-3-9-november-2025-a-call-to-action-to-improve-patient-safety2025-10-23T14:00:13+01:00#MedSafetyWeek (3-9 November 2025): A call to action to improve patient safetyThe annual #MedSafetyWeek campaign takes place from 3 to 9 November 2025. This year’s campaign theme is ‘we can all help make medicines safer.’tag:www.gov.uk,2005:/drug-safety-update/paracetamol-and-pregnancy-reminder-that-taking-paracetamol-during-pregnancy-remains-safe2025-09-23T17:41:18+01:00Paracetamol and pregnancy - reminder that taking paracetamol during pregnancy remains safePatients should be reminded and reassured that there is no evidence that taking paracetamol during pregnancy causes autism in children. Paracetamol is recommended as the first-choice pain reliever for pregnant women, used at…